These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 16688207)

  • 1. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
    Rivière C; Danos O; Douar AM
    Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.
    Sumner-Jones SG; Davies LA; Varathalingam A; Gill DR; Hyde SC
    Gene Ther; 2006 Dec; 13(24):1703-13. PubMed ID: 16855618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
    Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
    Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
    Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
    Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
    Wang C; Wang CM; Clark KR; Sferra TJ
    Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
    Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
    Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
    Chao H; Liu Y; Rabinowitz J; Li C; Samulski RJ; Walsh CE
    Mol Ther; 2000 Dec; 2(6):619-23. PubMed ID: 11124063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
    Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
    J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.
    Blankinship MJ; Gregorevic P; Allen JM; Harper SQ; Harper H; Halbert CL; Miller AD; Chamberlain JS
    Mol Ther; 2004 Oct; 10(4):671-8. PubMed ID: 15451451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
    Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.
    Sumner-Jones SG; Gill DR; Hyde SC
    J Virol; 2007 Nov; 81(22):12360-7. PubMed ID: 17855531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
    Le HT; Yu QC; Wilson JM; Croyle MA
    J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into skeletal muscle using novel AAV serotypes.
    Louboutin JP; Wang L; Wilson JM
    J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
    Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
    Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors.
    Kok MR; Voutetakis A; Yamano S; Wang J; Cotrim A; Katano H; Bossis I; Chiorini JA; Tran SD; Tak PP; Baum BJ
    J Gene Med; 2005 Apr; 7(4):432-41. PubMed ID: 15515118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
    Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
    J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.